Home
ABBV
ABBV News

Latest AbbVie Inc. (ABBV) News on August 31, 2025

The Smartest Dividend Stocks to Buy With $500 Right Now

Motley Fool

21 hours ago

The Smartest Dividend Stocks to Buy With $500 Right Now

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?

Zacks

2 days ago

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Zacks

2 days ago

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

MT Newswires

2 days ago

DBS Bank Adjusts Price Target on AbbVie to $208 From $188, Maintains Hold Rating

Pharmaceutical Technology

2 days ago

Health Canada issues NOC to AbbVie’s upadacitinib for giant cell arteritis

Assessing AbbVie’s Valuation After $1.2B Bretisilocin Acquisition Announcement

Simply Wall St.

2 days ago

Assessing AbbVie’s Valuation After $1.2B Bretisilocin Acquisition Announcement

Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma

Insider Monkey

2 days ago

Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

Insider Monkey

2 days ago

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

2 Reasons to Watch ABBV and 1 to Stay Cautious

StockStory

2 days ago

2 Reasons to Watch ABBV and 1 to Stay Cautious

These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth

Barchart

2 days ago

These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth

Healthcare Stocks Are ‘Priced at Panic Levels.’ It’s Time to Buy.

Barrons.com

2 days ago

Healthcare Stocks Are ‘Priced at Panic Levels.’ It’s Time to Buy.

What Is the Intent Behind AbbVie's Recent Acquisition Spree?

Zacks

4 days ago

What Is the Intent Behind AbbVie's Recent Acquisition Spree?

RINVOQ® (upadacitinib) Receives Health Canada Notice of Compliance (NOC) for Giant Cell Arteritis in adults

CNW Group

4 days ago

RINVOQ® (upadacitinib) Receives Health Canada Notice of Compliance (NOC) for Giant Cell Arteritis in adults

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

GlobeNewswire

4 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

Argus Research

5 days ago

The Argus High-Yield Model Portfolio

AbbVie’s (ABBV) Fell in Line with the Broader Biopharmaceutical Industry

Insider Monkey

5 days ago

AbbVie’s (ABBV) Fell in Line with the Broader Biopharmaceutical Industry

ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression

Zacks

5 days ago

ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression

AbbVie agrees to acquire Gilgamesh’s bretisilocin for $1.2bn

Pharmaceutical Technology

5 days ago

AbbVie agrees to acquire Gilgamesh’s bretisilocin for $1.2bn

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030

GlobeNewswire

5 days ago

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030

AbbVie dives back into the neuro pool with a $1.2B psychedelics play

Pharma Voice

5 days ago

AbbVie dives back into the neuro pool with a $1.2B psychedelics play

How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock

Benzinga

5 days ago

How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock

MT Newswires

5 days ago

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires

5 days ago

Sector Update: Health Care Stocks Fall Monday Afternoon

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

PR Newswire

6 days ago

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

AbbVie (ABBV): Evaluating Valuation as Rinvoq Achieves Phase 3 Success in Severe Alopecia Areata

Simply Wall St.

6 days ago

AbbVie (ABBV): Evaluating Valuation as Rinvoq Achieves Phase 3 Success in Severe Alopecia Areata

3 Unstoppable Dividend Stocks to Buy Right Now

Motley Fool

8 days ago

3 Unstoppable Dividend Stocks to Buy Right Now

JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9

Insider Monkey

8 days ago

JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

Zacks

9 days ago

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth

Zacks

9 days ago

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth

AbbVie seeks Rinvoq alopecia approval after second Phase III success

Clinical Trials Arena

9 days ago

AbbVie seeks Rinvoq alopecia approval after second Phase III success

The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil and AbbVie

Zacks

9 days ago

The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil and AbbVie

AbbVie's Rinvoq Shines In Hair Loss Trial

GuruFocus.com

9 days ago

AbbVie's Rinvoq Shines In Hair Loss Trial

Top Stock Reports for Alphabet, Exxon Mobil & AbbVie

Zacks

9 days ago

Top Stock Reports for Alphabet, Exxon Mobil & AbbVie

AbbVie (ABBV) Reports Positive Phase 3 Results For RINVOQ In Alopecia Areata Study

Simply Wall St.

9 days ago

AbbVie (ABBV) Reports Positive Phase 3 Results For RINVOQ In Alopecia Areata Study

MT Newswires

10 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

10 days ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

Benzinga

10 days ago

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata

PR Newswire

10 days ago

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata

2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer

Motley Fool

10 days ago

2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer

Does AbbVie's US$10 Billion U.S. Manufacturing Bet Shift the Long-Term Outlook for ABBV?

Simply Wall St.

10 days ago

Does AbbVie's US$10 Billion U.S. Manufacturing Bet Shift the Long-Term Outlook for ABBV?

ACCESS Newswire

10 days ago

Interim Report H1 2025: Group Revenue and Earnings Record-High

ACCESS Newswire

11 days ago

Record Quarter for Gubra, but Revised Outlook for the CRO Business

Does Cobenfy Have the Potential to Become a Top Drug for BMY?

Zacks

11 days ago

Does Cobenfy Have the Potential to Become a Top Drug for BMY?

AbbVie Rises 11.5% in a Month: Buy, Hold or Sell the Stock?

Zacks

11 days ago

AbbVie Rises 11.5% in a Month: Buy, Hold or Sell the Stock?

Q2 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks

StockStory

11 days ago

Q2 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks

Strategic Partnerships Power Tempus AI's Healthcare Expansion

Zacks

12 days ago

Strategic Partnerships Power Tempus AI's Healthcare Expansion

MT Newswires

12 days ago

AbbVie Closes Acquisition of Capstan Therapeutics

AbbVie Completes Acquisition of Capstan Therapeutics

PR Newswire

12 days ago

AbbVie Completes Acquisition of Capstan Therapeutics

SkinMedica® Unveils Its Newest Hydration Hero

PR Newswire

12 days ago

SkinMedica® Unveils Its Newest Hydration Hero

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

GlobeNewswire

12 days ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Zacks

13 days ago

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today

Motley Fool

13 days ago

If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today

Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry

Benzinga

15 days ago

Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry

3 Dividend Stocks to Double Up On Right Now

Motley Fool

16 days ago

3 Dividend Stocks to Double Up On Right Now

AbbVie (ABBV) Invests US$195 Million To Expand U.S. Pharmaceutical Production

Simply Wall St.

18 days ago

AbbVie (ABBV) Invests US$195 Million To Expand U.S. Pharmaceutical Production

MT Newswires

18 days ago

Cantor Fitzgerald Adjusts Price Target on AbbVie to $215 From $210, Maintains Overweight Rating

AbbVie to build API plant in Illinois as it steps up US production

BioPharma Dive

18 days ago

AbbVie to build API plant in Illinois as it steps up US production

AbbVie expands North Chicago API production with $195m investment

Pharmaceutical Technology

18 days ago

AbbVie expands North Chicago API production with $195m investment

ABBV Q2 Deep Dive: Immunology and Neuroscience Growth Outpace Aesthetics, Guidance Trimmed

StockStory

18 days ago

ABBV Q2 Deep Dive: Immunology and Neuroscience Growth Outpace Aesthetics, Guidance Trimmed

5 Insightful Analyst Questions From AbbVie’s Q2 Earnings Call

StockStory

18 days ago

5 Insightful Analyst Questions From AbbVie’s Q2 Earnings Call

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients

Chicago Tribune

18 days ago

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients

MT Newswires

18 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

19 days ago

AbbVie Invests $195 Million to Construct New Manufacturing Facility in Illinois

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

PR Newswire

19 days ago

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?

Benzinga

19 days ago

If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

GlobeNewswire

19 days ago

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

GlobeNewswire

19 days ago

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

ACCESS Newswire

19 days ago

Markus Rohrwild Appointed New CEO of Gubra in a Planned Succession Process

MT Newswires

19 days ago

Mizuho Securities Adjusts Nomad Foods Price Target to $20 From $23, Maintains Outperform Rating

MT Newswires

20 days ago

Rothschild & Co Redburn Adjusts AbbVie Price Target to $248 From $240

AbbVie’s upadacitinib raises the bar for alopecia areata

Clinical Trials Arena

20 days ago

AbbVie’s upadacitinib raises the bar for alopecia areata

Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth

GlobeNewswire

20 days ago

Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

GlobeNewswire

20 days ago

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

My 3 Favorite Stocks to Buy Right Now

Motley Fool

21 days ago

My 3 Favorite Stocks to Buy Right Now

3 Stocks Retirees Should Absolutely Love

Motley Fool

22 days ago

3 Stocks Retirees Should Absolutely Love

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

Zacks

23 days ago

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

Epkinly breaks ground in Phase III FL trial

Pharmaceutical Technology

23 days ago

Epkinly breaks ground in Phase III FL trial

Argus Research

23 days ago

Daily – Vickers Top Buyers & Sellers for 08/08/2025

MT Newswires

23 days ago

AbbVie Shares Rise After Upgrade From Daiwa Securities

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

GlobeNewswire

24 days ago

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

GlobeNewswire

24 days ago

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights

PR Newswire

24 days ago

REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights

REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy

PR Newswire

24 days ago

REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy

MT Newswires

24 days ago

Daiwa Securities Upgrades AbbVie to Outperform From Neutral, Adjusts Price Target to $214 From $190

Morningstar Research

24 days ago

Analyst Report: Royalty Pharma plc

Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029

GlobeNewswire

25 days ago

Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

GlobeNewswire

25 days ago

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Get Ready, JUVÉDERM® Day is Calling!

PR Newswire

25 days ago

Get Ready, JUVÉDERM® Day is Calling!

Argus Research

25 days ago

The Fed Stands Pat as Tariffs Kick In

Hungary's Richter says some US exports face tariff challenges, but flagship drug exempt

Reuters

25 days ago

Hungary's Richter says some US exports face tariff challenges, but flagship drug exempt

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

a month ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?

Barchart

a month ago

AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?

AbbVie Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

AbbVie Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency

PR Newswire

a month ago

Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency

MT Newswires

a month ago

HSBC Adjusts Price Target on AbbVie to $210 From $205, Maintains Buy Rating

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

PR Newswire

a month ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Pharma CEOs downplay impact of tariffs amid rising cost concerns

Pharmaceutical Technology

a month ago

Pharma CEOs downplay impact of tariffs amid rising cost concerns

J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?

Zacks

a month ago

J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?

MT Newswires

a month ago

BNP Paribas Exane Adjusts AbbVie Price Target to $197 From $195, Maintains Neutral Rating

Share on Social Networks: